Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Valneva Se ADR
(NQ:
VALN
)
8.520
-0.090 (-1.05%)
Streaming Delayed Price
Updated: 1:19 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Valneva Se ADR
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
US Dept of Defense Ends Vaccine Supply Pact With Valneva For Viral Brain Infection
August 18, 2022
Via
Benzinga
Valneva Cuts FY22 COVID-19 Vaccine Sales Outlook, Needs Funding To Invest In Next-Gen COVID-19 Shot
August 11, 2022
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Via
Benzinga
Why Is Valneva (VALN) Stock Up 85% Today?
June 21, 2022
Valneva (VALN) stock is rocketing higher on Tuesday following news that Pfizer (PFE) is taking a stake in the vaccine company.
Via
InvestorPlace
Why Are Valneva Shares Rallying Today
June 21, 2022
Via
Benzinga
Pfizer And Valneva Commence Late-Stage Lyme Disease Study
August 08, 2022
Pfizer (NYSE: PFE) and Valneva SE (NASDAQ: VALN) initiated the Phase 3 VALOR study of its vaccine candidate VLA15 for Lyme disease patients.
Via
Benzinga
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
August 08, 2022
From
Pfizer Inc.
Via
Business Wire
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
Valneva SE (NASDAQ: VALN) is trying to come back after a disappointing COVID-19 shot by betting on the Lyme disease vaccine. Climate change is spurring more cases of tick-borne Lyme disease.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
Via
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 20, 2022
Via
Benzinga
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
June 24, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Via
Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 24, 2022
Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of their outstanding shares is at $47.6 million. As per the press...
Via
Benzinga
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
June 23, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
Via
Benzinga
U.S. Markets Open Higher; Jobless Claims Drop To 229,000
June 23, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 200 points on Thursday.
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
June 22, 2022
Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday.
Via
Benzinga
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
June 21, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday.
Via
Benzinga
Why Shares Of Valneva SE Are Soaring Today
June 21, 2022
Valneva SE (NASDAQ: VALN) shares are trading higher after the company and Pfizer announced they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and...
Via
Benzinga
67 Biggest Movers From Yesterday
June 22, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Via
Benzinga
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
June 21, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday.
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
June 21, 2022
Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Via
Benzinga
Gas Price Predictions: How Much Lower Can Gas Prices Go This Summer?
June 21, 2022
Gas price predictions are worth checking in on today as the national average in the U.S. managed to slip back below $5 per gallon.
Via
InvestorPlace
U.S. Markets Open Higher; Lennar Earnings Top Views
June 21, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 500 points on Tuesday.
Via
Benzinga
Valneva Soars 88% After Pfizer Invests $95 Million For A Hefty Stake
June 21, 2022
The companies are working together in Lyme disease.
Via
Investor's Business Daily
AMD Stock Alert: 16 Things to Know About AMD’s New Processors
June 21, 2022
Advanced Micro Devices (AMD) stock is rising higher on Tuesday after announcing a new generation of Ryzen Embedded processors.
Via
InvestorPlace
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
June 21, 2022
Gainers Valneva SE (NASDAQ: VALN) shares rose 83.6% to $25.18 in pre-market trading following Pfizer agreement to acquire an 8.1% stake.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.